Mean tumor volume by day 36 was 285.2 ± 23.7 mm3 in the CD47-shRNA group and 714.1 ± 31.8 mm3 in the control shRNA group (Fig. 5B,C, P < 0.05). This evidence concerns the gene CD47 and neoplasm.